Status:
COMPLETED
Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients
Lead Sponsor:
The Cleveland Clinic
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Venous thromboembolism (VTE) is a serious source of hospital morbidity and mortality. Chemoprophylaxis with heparin has been shown to reduce the occurrence of VTE, but it increases the risk of bleedin...
Detailed Description
Specific Aim: Assess the effects of a VTE risk calculator embedded in the admission order set vs. usual care on physician behavior and patient outcomes in a randomized trial Research Strategy: Util...
Eligibility Criteria
Inclusion
- All adult patients (age ≥18 years) admitted to a medical service, including intensive care units, between September 1, 2017 and August 31, 2018 will be eligible.
Exclusion
- patients not eligible to receive VTE prophylaxis because they are already receiving anticoagulation for another purpose (e.g. warfarin for atrial fibrillation or LMWH for DVT or PE present on admission),
- patients admitted with a terminal condition who are receiving comfort care only
- Surgical patients who are admitted to the medical service temporarily (e.g. hip fracture)
Key Trial Info
Start Date :
December 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 14 2019
Estimated Enrollment :
90537 Patients enrolled
Trial Details
Trial ID
NCT03243708
Start Date
December 4 2017
End Date
April 14 2019
Last Update
May 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Health System
Cleveland, Ohio, United States, 44195